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Background: Vitamin D receptor (VDR) deficiency contributes to the development of experimental inflammatory
bowel disease (IBD) in several different models. T cells have been shown to express the VDR, and T cells are targets
of vitamin D. In this article we determined the effects of VDR expression on CD8+ T cells.
Results: VDR KO CD8+ T cells, but not WT CD8+ T cells, induced colitis in Rag KO recipients. In addition, co-transfer
of VDR KO CD8+ T cells with naïve CD4+ T cells accelerated colitis development. The more severe colitis was
associated with rapidly proliferating naïve VDR KO CD8+ T cells and increased IFN-γ and IL-17 in the gut. VDR KO CD8+ T
cells proliferated in vitro without antigen stimulation and did not downregulate CD62L and upregulate CD44 markers
following proliferation that normally occurred in WT CD8+ T cells. The increased proliferation of VDR KO CD8+ cells was
due in part to the higher production and response of the VDR KO cells to IL-2.
Conclusions: Our data indicate that expression of the VDR is required to prevent replication of quiescent CD8+ T cells.
The inability to signal through the VDR resulted in the generation of pathogenic CD8+ T cells from rapidly proliferating
cells that contributed to the development of IBD.
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Inflammatory bowel diseases (IBD) are immune medi-
ated diseases that result because of a complex inter-
action between genetics and the environment. Over 3.6
million people in the US and Europe suffer from IBD.
Environmental factors that contribute to IBD develop-
ment include the composition of the normal bacterial
flora [1] and perhaps vitamin D. A major source of vita-
min D results from its manufacture via a photolysis re-
action in the skin and vitamin D available from sunlight
exposure is significantly less in northern climates, and
especially low during the winter [2]. In addition dietary
intake of vitamin D is problematic since there are few* Correspondence: mxc69@psu.edu
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unless otherwise stated.foods, which are naturally rich in vitamin D. There is
evidence for a link between vitamin D availability and
the prevalence of immune mediated diseases in general
and IBD in particular [3,4]. In addition, experimental
models of IBD are more severe in vitamin D receptor
(VDR) KO and vitamin D deficient models [5]. Vitamin
D is likely an environmental factor that affects the devel-
opment of IBD.
T cells have been shown to express the VDR, and T
cells are both direct and indirect targets of vitamin D. In
addition, the active form of vitamin D (1,25(OH)2D3)
suppressed the development of experimental models of
T cell mediated diseases including IBD, multiple sclerosis
and type-1 diabetes [6,7]. Conversely, vitamin D defi-
ciency and/or VDR deficiency resulted in an exacerba-
tion of experimental IBD [5]. Expression of the VDR
does not affect the development of normal numbers
of CD4 and CD8αβ T cells in the thymus or in thetd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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IL-17, and IFN-γ, proliferate more rapidly in a mixed
lymphocyte reaction and induce more severe colitis than
WT CD4 cells [5,10]. Mice with VDR specific KO in T
cells have increased incidence of experimental auto-
immune encephalomyelitis and VDR expression in T
cells was shown to be essential for the effectiveness of
1,25(OH)2D3 for the suppression of disease [11]. 1,25
(OH)2D3 in vitro suppressed the proliferation of both
CD4+ and CD8+ T cells and inhibited the production of
IFN-γ, and IL-2 [12,13]. Vitamin D is required for the
development of two regulatory cell populations: NKT
cells and CD8αα expressing T cells [9,14]. In addition,
1,25(OH)2D3 induces CD4
+ T regulatory cells in vitro
and in vivo [15,16]. Resting and activated CD8+ T cells
have been shown to express higher levels of the VDR
than CD4+ T cells; however, the physiological role of
vitamin D and the VDR in regulating CD8+ T cell func-
tion has not been examined [17].
CD8+ T cells can be pathogenic, protective or tolero-
genic. Pathogenic and protective CD8+ T cells share
common features including IFN-γ and TNF-α produc-
tion as well as cytotoxicity [18,19]. A pathogenic role for
CD8+ T cells has been shown for IBD [18]. Heat shock
protein-specific CD8+ T cells transferred severe symp-
toms of IBD in immunodeficient mice due to the pro-
duction of IFN-γ and TNF-α [18]. Conversely, several
CD8+ T cell subsets have been shown to act in a sup-
pressive or regulatory manner. CD8+ T cells that do not
express CD28 (CD8/CD28−), but produced IL-10 in hu-
man peripheral blood, suppressed cytotoxic activity and
proliferation in vitro [20]. In mice, IL-10 and TGF-β
producing CD8/CD28− regulatory T cells inhibited ex-
perimental IBD development in the T cell transfer model
of IBD [21]. Human CD8/CXCR3+ cells are a second
population of human regulatory CD8+ T cells [22]. Like
the CD8/CD28− T cells, the mouse homologs of the hu-
man CD8/CXCR3+ T cells (CD8/CD122+) suppressed
the development of T cell-transfer colitis via the produc-
tion of IL-10 [23]. Lastly, CD8αα+TCRαβ+ cells found in
the intraepithelial lymphocytes (IEL) of the small intes-
tine (SI) have IL-10 mediated regulatory abilities and can
suppress development of T cell-transfer colitis [24,25].
In experimental IBD CD8+ T cells can either cause or
protect from disease development.
Here we determined the effects of vitamin D on
CD8αβ+ T cells. VDR KO mice had increased numbers
of naïve CD8+ T cells that when purified and then trans-
ferred to Rag KO recipients induced colitis as deter-
mined by histological staining. In addition, co-transfer of
VDR KO CD8+ T cells with naïve WT CD4+ cells accel-
erated the development of colitis in Rag KO recipients.
The cause of the VDR KO CD8+ T cell pathogenicity
was due to the uncontrolled proliferation of CD8+ Tcells in general and naïve CD8+ T cells in particular. In
addition, VDR KO CD8+ T cells overproduced IL-2. The
rapidly dividing VDR KO CD8+ T cells accumulated in
the gut where they induced IFN-γ and IL-17 production.Methods
Mice
WT, VDR KO, IL-10 KO, IL-10/VDR double (D) KO
and Rag KO mice all on the C57BL/6 background were
bred in the animal facilities at the Pennsylvania State
University (University Park, PA). The original VDR KO
breeders were a gift from Dr. Marie Demay (Harvard
University, Boston MA) and the DKO mice were gener-
ated as previously described [5]. All other breeders were
originally from Jackson Laboratories (Bar Harbor, ME).
Experimental procedures were approved by the Office of
Research Protection Institutional Animal Care and Use
Committee at the Pennsylvania State University.T cell isolation
CD4+ or CD8+ T cells were purified from the spleen
using the mouse CD4+ or CD8+ Recovery Column kit
and the manufacturer’s instructions (Cedarlane, Bur-
lington, NC). Column purification was followed by cell
sorting (Cytopeia Influx, Seattle, WA) of CD4+, CD8+,
CD4+CD45RBhigh, CD8+CD28+/-, CD8+CD122+ T cell
subsets. Post-sorting analysis confirmed that the purity
of the T cells was >99% (Additional file 1: Figure S1A).
IELs were isolated for analyses by removing the Peyer’s
patches and splitting the SI lengthwise followed by
cutting the SI into 0.5 cm pieces. The pieces were incu-
bated twice in HBSS containing 0.15 μg/ml dithiothrei-
tol and 5%FBS (Sigma-Aldrich, St. Louis, MO) for
20 min at 37°C under 200 rpm rotation. The IEL were
collected from the interface of 40/80% Percoll gradients
(Sigma-Aldrich).Adoptive transfer
All transfers used T cells from the spleens of the donor
mice. Groups of Rag KO mice were injected intraperi-
toneally (i.p.) with 1 × 106 CD8+ cells or CD8 T cell
sorted subsets (CD28−, CD28+ or CD122+) from WT,
VDR KO, IL-10 KO or IL-10/VDR DKO mice. Sorting
purity and gating strategies are in Additional file 1:
Figure S1. For the co-transfer experiments, Rag KO
mice were injected i.p. with 1 × 106 WT or VDR KO
(CD45.2+) CD8+ T cells on day -1 and 4 × 105 WT
(CD45.1+) CD4+CD45RBhigh cells on day 0. Both CD8
and CD4+CD45RBhigh cells were resuspended in 200 μL
PBS. The Rag KO recipients were weighed weekly and
euthanized after 7 or 8 wks.
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Colitis symptoms measured included: weight loss, colon/
body weight (BW) ratios, histopathology scores, diarrhea,
rectal bleeding, and rectal prolapse exactly as described [5].
1 cm of the distal colon was fixed in formalin and sent to
the Penn State University Animal Diagnostic Laboratories
(University Park, PA) for sectioning and haematoxylin &
eosin (H&E) staining. Inflammation and epithelial injury
of the colons were scored blindly by two individuals for in-
flammation (0-4) and epithelial hyperplasia (0-4) [5]. Total
histopathology scores ranged from 0-8.
BrdU incorporation assay
Rag KO mice were injected i.p. with 50 μl of 25 mg/ml
BrdU dissolved in PBS every two days. The mice were
euthanized at d3, d8 and d14 and the MLN and IEL
were fixed with ice-cold 95% ethanol and paraformalde-
hyde digested with DNaseI solution (Sigma).
Flow cytometry
Cells were stained with: FITC anti-CD8α, FITC anti-
CD8β, FITC anti-CD45RB, PE anti-CD45.1, PE anti-
CD28, PE anti-CD122, PE anti-CD4, PE anti-CD44, PE
anti-CD25, PE-Texas Red (ECD) anti-CD4, PECy5 anti-
CD62L, PECy5 anti-TCRβ and PECy7 anti-CD8α (BD
Pharmingen, San Jose, CA) for surface markers. Gating
strategies for FACS analysis are shown in Additional
file 2: Figure S2. For BrdU incorporation assays, cells
were stained with Biotin anti-BrdU, FITC streptavidin
and Biotin Mouse IgG1, κ isotype control (Biolegend,
San Diego, CA). For intracellular cytokine staining, IEL
were stimulated with PMA (0.1 μg/ml, Sigma), ionomycin
(0.5 μg/ml, Sigma) and Brefeldin A (10 μg/ml, Sigma) for
6 h, fixed with 4% paraformadehyde (Sigma-Aldrich),
permeabilized with 0.1% saponin (Sigma-Aldrich), and
stained with FITC anti-IFNγ, PE anti-IL-17A, or the
FITC/PE labeled Rat IgG1 isotype controls (BD Phar-
mingen). Flow cytometry was done on a FC500 bench
top cytometer (Beckman Coulter, Brea, CA) and the
data was analyzed with FlowJo 7.6.5 software (TreeStar,
Ashland, OR).
Cell culture and CFSE staining
Purified CD8+ T cells were labeled with CFSE using Cell
TRave CFSE Cell Proliferation Kit (Life Technologies,
Grand Island, NY). The labeled CD8+ T cells (2 × 106
cells/ml) were cultured with plate bound anti-CD3 (5 μg/
ml) and anti-CD28 (5 μg/ml, BD Pharmingen) or 0.2 μg/
ml recombinant IL-2 with/without neutralizing IL-2 anti-
bodies (50 ng/ml, Clone: S4B6, BD Pharmingen). Super-
natants were collected from 3d cultures of unstimulated
or CD3/CD28 stimulated CD8+ T cells, and IL-2 in the
supernatant was evaluated using an ELISA kit and the
manufacturer’s instructions (BD Pharmingen).Quantitative real-time PCR
Total RNA was isolated from SI and colon of mice fol-
lowing the manufacturer’s instructions (Qiagen, Valencia,
CA). cDNA was synthesized by using the TaqMan re-
verse transcription reagents kit (Applied Biosystems,
Carlsbad, CA) and was amplified for cytokines Ifn-γ,
Il-17A and Il-10 with SYBR green mix (BioRad, Hercules,
CA) by MyiQ Single-Color Real-Time PCR machine
(BioRad). Expression levels of these cytokines were nor-
malized by GAPDH and calculated by using ΔΔCt
method [2^(Ctsample –Ctctrl)].
Statistics
Statistical analyses were performed by GraphPad (PRISM
software, La Jolla, CA). Data are presented as mean ± SEM
values from two or three experiments. Unpaired Student’s
t test, and ANOVAs with Bonferroni post-hoc tests were
used to calculate statistical significance. Values are signifi-
cantly different with P-values of *P < 0.05, **P < 0.01, and
***P < 0.001.
Results
CD8+ T cells from VDR KO mice transfer IBD to Rag KO
recipients
CD8+ T cells from WT and IL-10 KO mice did not in-
duce colitis when transferred to Rag KO recipients and
histopathology of the colons from Rag KO mice that re-
ceived 106 WT or IL-10 KO CD8+ T cells were normal
(Figure 1A). Conversely, Rag KO mice that received 106
VDR KO or IL-10/VDR DKO CD8+ T cells showed
severe inflammation in the colon including hyperplasia
and infiltration of immune cells (Figure 1A). The Rag
KO mice that received CD8+ T cells from DKO mice
lost a significant amount of their starting BW by 8 wks
(Figure 1B). In fact the Rag KO recipients of DKO CD8+
T cells developed a fulminating form of IBD that resem-
bled the IBD that develops in the DKO mice [5]. Rag
KO mice that received no cells (CTRL) gained weight
over the 8 wk study and Rag KO mice that received WT,
VDR KO and IL-10 KO CD8+ T cells maintained their
BW (Figure 1B). None of the over 20 Rag KO recipients
of VDR KO CD8+ T cells lost weight even though the
mice had intense inflammation in both the colon and SI
(data not shown and Figure 1A). The colon showed the
greatest degree of inflammation following transfer of
VDR KO CD8+ T cells to Rag KO recipients.
In order to determine what the differences were be-
tween VDR KO and WT CD8+ T cells, the CD8+ T cells
were characterized from WT and VDR KO mice. There
was a higher frequency of naïve (CD62Lhigh/CD44low)
and CD8/CD28− cells and a lower frequency of activated
(CD62Llow/CD44high) and CD8/CD122+ cells in the
spleen of VDR KO compared to WT mice (Figure 1C).
CD25+ expression on CD8+ T cells was low and less
A B
C D
E
Figure 1 CD8+ T cells from VDR KO mice induce colitis in Rag KO recipients. Sorted CD8+ T cells from WT, IL-10 KO, VDR KO, and IL-10/VDR
DKO mice were injected (106 cells per mouse i.p.) into Rag KO recipients. CTRL had no cell transfer. (A) Representative colonic sections from the
Rag KO recipients of CD8+ T cells 8 weeks post-transfer. Colonic samples were stained with H&E (scoring system in Methods) and were shown at
10× magnification; scale bar = 50 μm. Colon sections shown were rated: WT (score = 0), IL-10 KO (score = 0), VDR KO (score = 7), and DKO (score = 8).
(B) The percentage change in BW of Rag KO recipients of CD8+ T cells from WT, IL-10 KO, VDR KO and DKO mice. (C) The phenotype of CD8+
T cells from the spleen of WT and VDR KO mice. The splenic lymphocytes were prepared and stained for TCRβ, CD8β, CD44, CD62L, CD28 and
CD122 antibodies. The gating strategy is in Additional file 2: Figure S2A. (D) The percentage change in BW of the Rag KO recipients following
transfer of sorted CD8+/CD28+ or CD8+/CD28- cells from WT or VDR KO mice (106 cells per mouse i.p.). (E) Representative H&E stained colon
sections from Rag KO recipients of CD8+/CD28+ or CD8+/CD28- T cells at 8 weeks post-transfer. Colon sections shown were rated: CTRL
(score = 1), WT CD8/CD28+ (score = 3), WT CD8/CD28− (score = 3), VDR KO CD8/CD28+ (score = 6), VDR KO CD8/CD28− (score = 6). Values
represent the mean ± SEM of 5-8 mice per group and one representative of three independent experiments (A-E). Two-way ANOVA (B,D) or
Student’s t-tests (C), *P < 0.05, **P < 0.01.
Chen et al. BMC Immunology 2014, 15:6 Page 4 of 11
http://www.biomedcentral.com/1471-2172/15/6than 2% of the CD8+ T cells in VDR KO and WT mice
expressed CD25 (Additional file 1: Figure S1C). In
addition, there was no difference between expression
of CD25 on VDR KO and WT CD8+ T cells (Additional
file 1: Figure S1C). There was no difference in the total
number of splenocytes isolated from WT and VDR KO
mice and therefore changes in frequency also resulted in
changes in absolute numbers of cells. The frequency of
granzyme B+ cells was not different in CD3/CD28 acti-
vated VDR KO and WT CD8+ T cells (data not shown).
IL-17 and IL-10 were undetectable while IFN-γ was not
different in the supernatants from CD3/CD28 activated
VDR KO and WT CD8+ T cells (data not shown). The
finding of more regulatory CD8/CD28− and less regula-
tory CD8/CD122+ from the VDR KO mice was followed
up by doing additional transfers to Rag KO mice using
purified populations of these regulatory cell types.
Rag KO recipients of 106 sorted WT CD8/CD28− or
CD8/CD28+ T cells weighed the same as the CTRL Rag
KO mice that did not receive any cells (Figure 1D). Con-
versely, Rag KO recipients of 106 sorted VDR KO CD8/CD28− or CD8/CD28+ T cells lost significantly more
weight than the CTRL and WT CD8 T cell recipients
(Figure 1D). Sorted 106 CD8/CD122+ T cell transfers
from either WT or VDR KO mice did not induce weight
loss or colitis in Rag KO recipients (data not shown).
Histopathology of colonic tissue from Rag KO recipients
of VDR KO CD8+ subsets (CD28+/−) showed signifi-
cantly more inflammation and epithelial hyperplasia
than CTRL (Figure 1E). Histopathology of colonic tissue
from Rag KO recipients of WT CD8+ subsets (CD28+/−)
was not different from CTRL (Figure 1E). Increased col-
itis in Rag KO recipients of VDR KO CD8+ T cells is not
a result of a difference in the CD28+/− subpopulations.
VDR KO CD8+ T cells accelerate CD4/CD45RBhigh
cell-mediated colitis
The effect of CD8+ T cells on CD4/CD45RBhigh (naïve
CD4+) T cell induced colitis in Rag KO recipients was
examined. Rag KO mice were injected with 106 sorted
CD8+ T cells from CD45.2+ VDR KO or CD45.2+ WT
mice. The next day, the same Rag KO mice were injected
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duce colitis. Rag KO recipients of only naïve CD4 T cells
(CD4 only) lost 10% of their original BW, and weighed
significantly less than the CTRL mice at 7 wks post-
transfer (Figure 2A). Weight loss in the Rag KO recipients
of naïve WT CD4 cells plus WT CD8 T cells (CD4 +
WTCD8) was no different from the recipients of CD4 only
T cells (Figure 2A). Rag KO recipients of naïve WT CD4
plus VDR KO CD8 T cells (CD4 + KOCD8) lost 20% of
their original BW, which was significantly more weight
loss than any other group (Figure 2A). The colon/BW%
was lowest in the CTRL, intermediate in the CD4 only
and CD4 +WTCD8 groups and highest in the CD4 +
KOCD8 group (Figure 2B). The histopathology scores
from Rag KO recipients of CD4 + KOCD8 T cells were
6.5 ± 0.4, which was significantly higher than the scores
for all other groups (Figure 2C and data not shown). CD8+
T cells from VDR KO mice produced twice as much IFN-
γ and IL-17A than WT CD8+ T in the IEL of Rag KO re-
cipients (Figure 2D). In addition, the Rag KO recipients of
CD4 + KOCD8 T cells had significantly more total IFN-γ
and IL-17A producing cells in the IEL than recipients of
CD4 +WTCD8 T cells (Figure 2E). The same mice from
Figure 2 were used to measure the expression of Il-17ACTRL CD4 only
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Ifn-γ mRNA expression was higher in both the SI and
colon of the Rag KO recipients of CD4 + KOCD8 T cells
than the Rag KO recipients of CD4 +WTCD8 T cells
(Additional file 3: Figure S3). Rag KO recipients of CD8+
T cells from VDR KO mice had more IFN-γ and IL-17A
in the SI and colon that corresponded to the increased se-
verity of naïve CD4+ T cell induced colitis.
Increased CD8+, but reduced naive CD4+ T cells in VDR
KO cell recipients
The MLN and IEL of the SI were used to determine the
origin of T cells in the gastrointestinal tract of the Rag
KO recipients. The MLN and IEL were used since these
tissues normally have high frequencies of T cells and can
demonstrate the extent of immune reconstitution of Rag
KO mice following T cell transfer. 70 ± 5% of the IEL in
Rag KO recipients of only CD4 cells were the donor
CD4/CD45.1+ T cells (Figure 3A). The remaining cells in
the IEL (30%) were the resident Rag KO IEL cells (innate
immune cells) that did not express CD45.1 or CD8β. In
the Rag KO recipients of CD4 +WTCD8 cells, 36 ± 5%
of the IEL were CD4+ cells (CD45.1+) and 33 ± 4% were
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Figure 3 Frequencies of CD4+ and CD8+ T cells following CD4/CD8 co-transfer. (A) Dot plots show the frequencies of the reconstituted
CD4/CD45.1+ and CD8β/CD45.1− T cells in the IEL at week 7 post-transfer for CD4 only, CD4 +WTCD8 and CD4 + KOCD8 Rag KO recipients (mice
in Figure 2). (B) Bar charts showing the frequency of the reconstituted CD4/CD45.1+ and CD8β/CD45.1− T cells in the MLN. (C) Dot plots showing
the frequency of T cells in the Rag KO recipients that expressed CD8αα in the IEL. Data is from n = 6-8 mice per group and the values represent
the mean of three independent experiments ± SEM. ANOVA (A, B), or Student’s t-test (C), *P < 0.05, **P < 0.01, ***P < 0.001.
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The Rag KO recipients of the CD4 + KOCD8 cells had
fewer CD4+ cells (8 ± 1%) and more CD8αβ cells (64 ±
5%) than the other groups of mice (72% total T cells,
Figure 3A). The reconstitution of the MLN mirrored
the IEL in that the recipients of CD4 +WTCD8 cells
had approximately equal representation of CD4 and
CD8αβ cells in the MLN while the mice that received
CD4 + KOCD8 cells had significantly more CD8+ than
CD4+ T cells in the MLN (Figure 3B). There were no
differences in the total frequency of CD8αα+ expressing
T cells (18-21% of the T cells) in the IEL of the Rag KO
recipients of CD4 +WTCD8 or CD4 + KOCD8 T cells
(Figure 3C). Significantly more CD8+ T cells were re-
covered in the MLN and IEL of CD4 + KOCD8 than
CD4 +WTCD8 T cell transferred Rag KO recipient
mice.
Increased proliferation of VDR KO CD8+ T cells in vivo
Based on the finding of increased numbers (Figure 3) of
VDR KO CD8 cells in the IEL and MLN following co-
transfer to Rag KO mice; additional experiments were
done to determine whether VDR KO CD8 T cells prolif-
erate more rapidly than WT CD8 T cells. Sorted CD8+ T
cells were detectable in the MLN of Rag KO recipients
on d3 following transfer (Figure 4A). Conversely, there
were no T cells found in the IEL after 3 days (Figure 4A).
At d3 in the MLN most of the CD8+ T cells from
either WT or VDR KO donors were undergoing division
(88 ± 2% incorporated BrdU). There were two distinctpopulations of BrdU+ cells in the MLN; one with low-
mean fluorescence intensity (MFI, few rounds of prolif-
eration) and the other one with high-MFI (Figure 4A,
multiple rounds of proliferation). 61 ± 3% of VDR KO
CD8+ T cells were of the BrdU high-MFI phenotype and
only 41 ± 2% of the WT CD8+ T cells were BrdU high-
MFI (Figure 4A). On d8 there were also more high-MFI
profile VDR KO CD8+ T cells (51 ± 4%) than WT CD8+
T cells (39 ± 2%, Figure 4A). By day 14 in the MLN there
was a small population (16 ± 3%) of BrdU very high-MFI
VDR KO CD8+ T cells and significantly less of these cells
in the WT CD8+ T recipients (4 ± 1%, Figure 4A). CD8+ T
cells appeared in the IEL on d8 (Figure 4A). Significantly
fewer cells were BrdU high-MFI in the IEL of Rag KO re-
cipients of WT CD8+ T cells (8 ± 3%) than VDR KO CD8+
T cells (22 ± 2%, Figure 4A). There were also two dis-
tinct peaks of BrdU incorporation evident at d14 in the
IEL samples and again the high-MFI peak was over
represented in the recipients of VDR KO CD8+ T cells
(Figure 4A). Total VDR KO CD8+ T cells were prolifer-
ating faster than WT CD8+ T cells in vivo.
To identify which T cell subsets were undergoing rapid
proliferation in the Rag KO recipients, the BrdU MFI-high
cells from Figure 4A were phenotyped. Naïve CD8+ T cells
(CD62LhighCD44low) from VDR KO mice proliferated more
than their WTcounterparts in the MLN and IEL on d3 and
d8 post-transfer (Figure 4B). Conversely, activated CD8+ T
cells (CD62LlowCD44high) from VDR KO mice proliferated
at the same rate (differences were not significant) as acti-
vated cells from WT mice post-transfer (Figure 4B). More
naive CD8+
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Figure 4 Proliferation of CD8+ T cells in vivo. (A) Histograms showing BrdU incorporation in the MLN or IEL following transfer of sorted 106
WT or VDR KO CD8+ T cells into Rag KO recipients from 3 to 14 days post-transfer. Shaded histograms showed the BrdU isotype control staining,
and open histograms were BrdU staining. (B) Different CD8+ subsets were evaluated for BrdU incorporation and graphed at day 3 and day 8
post-transfer. Naïve CD8+ T cells are CD62LhighCD44low, and activated CD8+ T cells are CD62LlowCD44high. Data is from n = 6-8 mice per group
and the values represent the mean of two independent experiments ± SEM. ANOVA, *P < 0.05, **P < 0.01.
Chen et al. BMC Immunology 2014, 15:6 Page 7 of 11
http://www.biomedcentral.com/1471-2172/15/6naïve VDR KO CD8+ T cells than naïve WT CD8+ T cells
were proliferating rapidly in vivo.
Increased proliferation of VDR KO CD8+ T cells in vitro
Proliferation of the CD8+ T cells from VDR KO and WT
mice was also tested in vitro. Even though there was very
little proliferation detected in the CD3/CD28 stimulated
cultures at d1, VDR KO CD8+ T cells had 2.4 ± 0.2%
of the cells proliferating while none of the WT CD8+ T
cells were proliferating (Figure 5A). On d2 there were
two rounds of proliferation evident in the WT CD8+ T
cell cultures and three rounds of proliferation in the
VDR KO CD8+ T cell cultures (Figure 5A). In addition,
there were significantly more VDR KO CD8+ T cells pro-
liferating (64 ± 3%) compared to WT CD8+ T cells (51 ±
2%) at d2. By d3 almost all of the cells in both cultures
had proliferated and there were no longer significant dif-
ferences in the frequency of CD8+ T cells that had
undergone proliferation (Figure 5A). VDR KO CD8+ T
cells were proliferating faster than WT CD8+ T cells
in vitro.
The CFSE stained cells in panel A were also stained to
look at naïve and activated cells in the cultures. On day
2 significantly more of the naïve (CD62LhighCD44low)
CD8+ T cells from VDR KO mice had proliferated in re-
sponse to CD3/CD28 stimulation than WT (Figure 5B).
By day 3 the naive VDR KO CD8+ T cells were prolifer-
ating rapidly in the presence and absence of CD3/CD28
stimulation while the naïve WT CD8+ T cells were not
(Figure 5B). The naïve VDR KO CD8+ cells were divid-
ing but not downregulating CD62L and upregulatingCD44 (Figure 5B). CD8+ T cells with an activated pheno-
type (CD62LlowCD44high) proliferated strongly in both
the WT and VDR KO cultures at both d2 and d3 post-
stimulation and there were no differences between the
proliferation of the activated VDR KO and WT CD8+ T
cells (Figure 5B). Phenotypically naïve VDR KO CD8+ T
cells proliferated with or without stimulation but did not
express activation markers as a result of proliferation.
VDR KO CD8+ T cells over-produce and respond to IL-2
robustly
The role of IL-2 in the increased proliferation of VDR KO
CD8+ T cells was determined. CD25 expression was not
different on VDR KO and WT CD8+ T cells (Additional
file 1: Figure S1D). 3 days of culture were required in
order to detect proliferation of CD8+ T cells in response to
IL-2 (d2 data not shown, Figure 6A). 24 ± 3% of WT CD8
T cells and 50 ± 4% of VDR KO CD8+ T cells divided at d3
following addition of IL-2 (Figure 6A). Addition of IL-2
plus IL-2 neutralizing antibodies prevented all of the WT
CD8+ T cell proliferation while VDR KO CD8+ T cells still
had 6 ± 2% undergoing proliferation in the presence of
neutralizing antibodies to IL-2 (Figure 6A). The superna-
tants from CD8+ T cells cultures stimulated with CD3 and
CD28 antibodies were evaluated for the production of IL-
2. Unstimulated VDR KO and WT CD8+ T cells did not
produce detectable IL-2 after 3 days in culture (Figure 6B).
CD3/CD28 stimulated VDR KO CD8+ T cells produced
2-fold more IL-2 than WT CD8+ T cells (Figure 6B). Over-
production of IL-2 contributes to the more rapid prolifera-
tion of CD3/CD28 activated VDR KO CD8+ T cells.
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Figure 5 Proliferation of CD8+ T cells in vitro. (A) Histograms show CFSE dilution induced following in vitro proliferation of sorted WT and
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CD28, and open histograms are CFSE dilution following stimulation. Values are mean ± SEM of the frequency of T cells that have divided and
diluted the CFSE label. (B) The CFSE labeled T cells in panel A were evaluated for CD8 subsets with or without (unstim) CD3/CD28 stimulation.
Naïve CD8+ T cells are CD62LhighCD44low, and activated CD8+ T cells are CD62LlowCD44high. The shaded histograms are the CFSE staining at the
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VDR KO CD8+ T cells proliferated more rapidly both
in vitro and in vivo. The increased rate of proliferation
following activation was associated with the over pro-
duction of IL-2 from the CD8+ T cells themselves. The
rapidly proliferating naïve donor VDR KO CD8+ T cells
found residence in the MLN first and then in the IEL of
the Rag KO mice where they out-competed the CD4+ T
cells and contributed to colitis development by inducing
IL-17A and IFN-γ production. In Rag KO recipients of
WT CD8+ T cells endogenously produced 1,25(OH)2D3
slowed down the proliferation of the T cells, while the
VDR KO CD8+ T cells could not respond to 1,25(OH)2D3. The 1,25(OH)2D3 also acted on WT CD8
+ T cells
to inhibit IL-17 and IFN- γ responses. In VDR KO mice
the CD8+ T cells with a naïve phenotype were over-
represented but their proliferation must have been con-
trolled since VDR KO mice did not develop overt colitis
symptoms [26]. VDR KO mice had normal FoxP3+ T
regulatory cells that may have prevented the naïve CD8+
T cells from expanding and causing colitis [26]. Naïve
CD8+ VDR KO T cells divided in vitro even in the ab-
sence of stimulation (Figure 5B). This is unique to the
VDR KO CD8+ T cells, since naïve CD4+ VDR KO T
cells proliferated at the same rate as naïve CD4+ WT T
cells (unpublished data and [26]). Proliferation was not
WT VDR KO VDR KOWT
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Figure 6 VDR KO CD8+ T cells produce more and proliferate more rapidly to IL-2. (A) Histograms show CFSE dilution following in vitro
proliferation of sorted WT and VDR KO CD8+ T cells in response to IL-2 stimulation or IL-2 stimulation with IL-2 neutralizing antibodies. The
shaded histograms show the CFSE stained T cells prior to stimulation. (B) IL-2 production was measured from sorted CD8+ T cells with or without
(unstim) CD3/CD28 stimulation. Supernatants were collected from 3d cultures of CD8+ T cells, and IL-2 in the supernatant was evaluated using
ELISA. Values are the means from two independent experiments ± SEM. N.D., not detected. ANOVA (A) or Student’s t-test (B), *P < 0.05.
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the proliferating CD8+ T cells were still CD62Lhigh/
CD44low. VDR expression must be required for the qui-
escence of naïve CD8+ T cells.
Naïve and memory CD8+ T cells use different cytokines
to regulate proliferation [27]. The proliferation of naïve T
cells requires IL-7 receptor (R) α, but not IL-15; conversely,
memory T cells use either IL-7Rα or IL-15 for proliferation
[27]. It would be difficult to envision how this differential
use of IL-7 versus IL-15 could account for the increased
proliferation of predominately naïve CD8+ T cells. Instead
it may be that developmentally the VDR is required to con-
trol the proliferation rate of the naïve CD8+ T cells but not
the differentiated effector or memory cells. Somewhat sur-
prisingly CD8+ T cells from VDR KO mice produced the
same amounts of granzyme B and IFN-γ as WT CD8+ T
cells (data not shown). Instead, CD8+ T cells from VDR
KO mice overproduced IL-2 that may act in a paracrine
manner on the CD8+ T cells themselves.
The original function of 1,25(OH)2D3 in the immune
system was shown to be as a suppressor of mitogen in-
duced proliferation [28]. Those early studies established
that 1,25(OH)2D3 suppressed T cell proliferation in both
CD4+ and CD8+ by blocking transition of the cycling
cells from early G1 to late G1 [29,30]. In addition, IL-2
was shown to be a target of 1,25(OH)2D3 treatments and
1,25(OH)2D3 inhibited production of IL-2 [31]. The in-
hibition of IL-2 expression was due to the direct inter-
action of the VDR/1,25(OH)2D3 complex that blocked
the binding of the NFATp/AP1 complex to the IL-2 pro-
moter [32]. The effects of 1,25(OH)2D3 on IL-2 contrib-
uted to the suppression of T cell proliferation by 1,25
(OH)2D3 but proliferation of 1,25(OH)2D3 treated T cells
was only partially reversed by exogenous IL-2 addition
[31]. Administration of exogenous IL-2 can increase thefrequency of CD8+ memory cells [33,34]. Autocrine IL-2
secretion by memory CD8+ T cells has been shown to be
a critical mechanism to maintain the CD8+ T cells [35].
The data in the VDR KO CD8+ T cells suggest that the
VDR must participate as a negative co-regulator of pro-
liferation and IL-2 production in CD8+ T cells. The data
further suggest that expression of the VDR may be im-
portant in regulation of the memory CD8+ response.
Vitamin D serves as a regulator of proliferation across
many different cell types. In addition to inhibiting the
proliferation of T cells, 1,25(OH)2D3 inhibits the prolif-
eration of keratinocytes, B cells, epithelial cells and sev-
eral different types of cancer cells [36,37]. Topical 1,25
(OH)2D3 inhibits proliferation and induces resolution of
psoriasis [37]. In addition, vitamin D deficiency is associ-
ated with an increase in several different types of cancer
[37]. VDR KO mice have increased epithelial cell prolif-
eration in the gastrointestinal tract and skin [38]. More
recently we have shown that in the immune system
control of homeostatic proliferation and apoptosis under-
lie the basic mechanisms whereby vitamin D regulates
TCRαβ/CD8αα and iNKT cell numbers [9,39]. Vitamin D
and the VDR seem to be master regulators of proliferation
across many cell types. In CD8+ T cells there is a selective
requirement for VDR signaling to control the numbers of
naïve CD8+ T cells in the periphery.
VDR KO CD8+ T cells induce colitis in the Rag KO re-
cipients. However, the Rag KO recipients of VDR KO
CD8+ T cells did not lose weight or develop overt symp-
toms of experimental IBD, suggesting that there must be
some regulatory cell or cytokine being produced to limit
the pathogenicity of the cells. There did not appear to
be any CD28− or CD122+ regulatory cell in the VDR KO
CD8+ T cells. Confirming the literature the Rag KO re-
cipients of IL-10 KO CD8+ T cells did not induce colitis
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fulminating form of IBD including rectal bleeding, and
significant weight loss. Therefore it seems that autocrine
IL-10 production by CD8+ T cells prevents overt colitis
induced by VDR KO CD8+ T cells.
The VDR is critical for controlling the rate of prolifer-
ation of naïve CD8+ T cells and the ability of the CD8+
T cells to both produce and respond to IL-2. In the ab-
sence of vitamin D signaling rapidly proliferating CD8+
T cells accumulate in the gut and contribute to the pro-
duction of IL-17 and IFN-γ. Autocrine production of IL-
10 limits VDR KO CD8+ T cell- induced colitis. In the T
cell transfer model of IBD other regulatory cells are ab-
sent that might inhibit the proliferation of the VDR KO
CD8+ T cells to control inflammation in the gastrointes-
tinal tract. Expression of the VDR halts the nonspecific
expansion of the naïve CD8+ T cells. Vitamin D control
of the CD8+ T cell response contributes to the mainten-
ance of gastrointestinal homeostasis.
Conclusions
In summary, VDR-deficiency results in the generation of
pathogenic CD8+ Tcells that contributes to the development
of IBD. The causes of the VDR KO CD8+ T cell induced
IBD was the rapid proliferation of CD8+ T cells in general
and naïve CD8+ T cells in particular, and the overproduction
and response to IL-2. Expression of the VDR prevents
homeostatic proliferation of CD8+ T cells and vitamin D
through the VDR maintains gastrointestinal homeostasis.
Additional files
Additional file 1: Figure S1. (A) CD8+ and CD4+column purification
was followed by cell sorting. Histograms show the frequencies of CD8+ T
cell subsets before (pre-sort) and after (post-sort) sorting of splenocytes
from WT and VDR KO mice. (B) CD4+CD45RBhigh pre-sort and post-sort
populations. The purity of the CD8+ and the CD4+CD45RBhigh T cells was
>99%. (C) Dot plots show the single staining for PE-conjugated CD45.1,
FITC-conjugated CD8β, and isotype controls for both PE and FITC staining
in the IEL for Figure 3A. (D) Lymphocytes were first gated on TCRβ+ cells. Bar
graphs shows the frequency of CD25+ T cells within the CD8+ population.
Values are the mean ± SEM of 8-10 mice per group. Student’s t-tests, n.s., not
significant.
Additional file 2: Figure S2. (A) Forward and side scatter of splenic
lymphocytes. CD8β+ cells were gated on and stained for CD28, CD122
and isotype controls. (B) Forward and side scatter for the IEL and MLN.
(C) Sorted CD8 cells were cultured without stimulation or with CD3/CD28
for 3 days and stained for CD8β, CD44 and CD62L antibodies. CFSE
staining was analyzed in the CD44low/CD62Lhigh (naive) and CD44high/
CD62Llow (activated) populations.
Additional file 3: Figure S3. mRNA expression for Ifn-γ, Il-17A, and Il-10
in the (A) small intestine and (B) colon of Rag KO recipients of CD4
+WTCD8 or CD4+KOCD8 (same mice as Figure 2). Data is from n=6-8
mice per group. ANOVA, *P <0.05.
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